These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial. Backeljauw PF, Miller BS, Dutailly P, Houchard A, Lawson E, Hale DE, Reiner B, Sperling MA, MS316 Study Group. Horm Res Paediatr; 2015 Jun; 83(4):268-79. PubMed ID: 25765099 [Abstract] [Full Text] [Related]
6. A rationale for the treatment of short stature in children with the combination of recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor-I (rhIGF-I). Bright GM, Fierro-Renoy JF. Growth Horm IGF Res; 2020 Jun; 52():101318. PubMed ID: 32252003 [Abstract] [Full Text] [Related]
7. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency. Guevara-Aguirre J, Rosenbloom AL, Vasconez O, Martinez V, Gargosky SE, Allen L, Rosenfeld RG. J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266 [Abstract] [Full Text] [Related]
8. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options. Kemp SF. BioDrugs; 2009 Feb; 23(3):155-63. PubMed ID: 19627167 [Abstract] [Full Text] [Related]
13. The role of recombinant human insulin-like growth factor-I in treating children with short stature. Collett-Solberg PF, Misra M, Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. J Clin Endocrinol Metab; 2008 Jan; 93(1):10-8. PubMed ID: 18165284 [Abstract] [Full Text] [Related]
15. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion. Camacho-Hübner C, Woods KA, Miraki-Moud F, Hindmarsh PC, Clark AJ, Hansson Y, Johnston A, Baxter RC, Savage MO. J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388 [Abstract] [Full Text] [Related]
16. Therapeutic applications of the insulin-like growth factors. Savage MO, Camacho-Hübner C, Dunger DB. Growth Horm IGF Res; 2004 Aug; 14(4):301-8. PubMed ID: 15231299 [Abstract] [Full Text] [Related]
17. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats. Fielder PJ, Mortensen DL, Mallet P, Carlsson B, Baxter RC, Clark RG. Endocrinology; 1996 May; 137(5):1913-20. PubMed ID: 8612531 [Abstract] [Full Text] [Related]
20. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature. Liu HJ, Wang LH, Chen L. Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056 [Abstract] [Full Text] [Related] Page: [Next] [New Search]